Catalyst Wire Dossier Catalyst Wire Dossier

Pyronaridine Artesunate (3:1)

pyronaridine artesunate · Medicines for Malaria Venture
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pyronaridine Artesunate (3:1), covering 2021-09-20 to 2021-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria [Phase 2]

See pricing